为您找到相关结果约103个

你是不是要搜索 期刊Saroglitazar 点击跳转

Saroglitazar for non-alcoholic steatohepatitis

Saroglitazar reduces obesity and associated inflammatory consequences in murine adipose tissue

SAROGLITAZAR REDUCES PREDICTOR LIPID BIOMARKERS OF CARDIOVASCULAR DISEASES

SAROGLITAZAR IN NONALCOHOLIC STEATOHEPATITIS PATIENTS-A SPECK OF OPTIMISM

Dual PPAR/agonist saroglitazar improves liver histopathology and biochemistry in experimental NASH models

Efficacy of Saroglitazar on Diabetes Dyslipidemia with Higher Triglyceride

Saroglitazar improves nonalcoholic fatty liver disease and metabolic health in liver transplant recipients

Saroglitazar for Nonalcoholic Fatty Liver Disease: A Single Centre Experience in 91 Patients

SAROGLITAZAR IN NONALCOHOLIC STEATOHEPATITIS PATIENTS-A SPECK OF OPTIMISM

Pharmacokinetics and Safety Evaluation of Single-Dose Saroglitazar Magnesium in Subjects with Hepatic

Neuroprotective potential of saroglitazar in 6-OHDA induced Parkinson's disease in rats

Study of Histological Effects of Saroglitazar in Patients with NASH

Deciphering the Precise Target for Saroglitazar Associated Antiangiogenic Effect: A Computational Synergistic

Virtual identification of novel PPAR alpha/gamma dual agonists by scaffold hopping of saroglitazar

Effect of dual PPAR-alpha/gamma agonist saroglitazar on diabetic retinopathy and oxygen-induced retinopathy

为您找到相关结果约103个

共103条页码: 1/7页15条/页